GW Pharmaceuticals plc announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was USD 148.222 million compared to USD 109.076 million a year ago. Operating loss was USD 22.812 million compared to USD 20.108 million a year ago. Net loss was USD 29.147 million compared to USD 24.946 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.07 a year ago. For the full year, total revenue was USD 527.205 million compared to USD 311.332 million a year ago. Operating loss was USD 51.765 million compared to USD 118.425 million a year ago. Net loss was USD 58.128 million compared to USD 9.019 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.02 a year ago.